HEADER GENE REGULATION 07-JUL-20 6ZOR TITLE OESTROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH COMPOUND 28 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ER,ER-ALPHA,ESTRADIOL RECEPTOR,NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 5 GROUP A MEMBER 1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS OESTROGEN RECEPTOR, GENE REGULATION EXPDTA X-RAY DIFFRACTION AUTHOR J.BREED REVDAT 3 31-JAN-24 6ZOR 1 REMARK REVDAT 2 19-JAN-22 6ZOR 1 JRNL REVDAT 1 20-JAN-21 6ZOR 0 JRNL AUTH J.S.SCOTT,T.A.MOSS,A.BALAZS,B.BARLAAM,J.BREED,R.J.CARBAJO, JRNL AUTH 2 E.CHIARPARIN,P.R.J.DAVEY,O.DELPUECH,S.FAWELL,D.I.FISHER, JRNL AUTH 3 S.GAGRICA,E.T.GANGL,T.GREBE,R.D.GREENWOOD,S.HANDE, JRNL AUTH 4 H.HATOUM-MOKDAD,K.HERLIHY,S.HUGHES,T.A.HUNT,H.HUYNH, JRNL AUTH 5 S.L.M.JANBON,T.JOHNSON,S.KAVANAGH,T.KLINOWSKA,M.LAWSON, JRNL AUTH 6 A.S.LISTER,S.MARDEN,D.F.MCGINNITY,C.J.MORROW,J.W.M.NISSINK, JRNL AUTH 7 D.H.O'DONOVAN,B.PENG,R.POLANSKI,D.S.STEAD,S.STOKES,K.THAKUR, JRNL AUTH 8 S.R.THRONER,M.J.TUCKER,J.VARNES,H.WANG,D.M.WILSON,D.WU,Y.WU, JRNL AUTH 9 B.YANG,W.YANG JRNL TITL DISCOVERY OF AZD9833, A POTENT AND ORALLY BIOAVAILABLE JRNL TITL 2 SELECTIVE ESTROGEN RECEPTOR DEGRADER AND ANTAGONIST. JRNL REF J.MED.CHEM. V. 63 14530 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 32910656 JRNL DOI 10.1021/ACS.JMEDCHEM.0C01163 REMARK 2 REMARK 2 RESOLUTION. 1.97 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.97 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.08 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 33210 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.680 REMARK 3 FREE R VALUE TEST SET COUNT : 1553 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 17 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.97 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.03 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.28 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2872 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2400 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2736 REMARK 3 BIN R VALUE (WORKING SET) : 0.2400 REMARK 3 BIN FREE R VALUE : 0.2420 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.74 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 136 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3437 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 28 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 44.32 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.83120 REMARK 3 B22 (A**2) : -8.63030 REMARK 3 B33 (A**2) : 0.79910 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.42630 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.300 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.172 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.143 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.180 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.147 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.943 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3568 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4854 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1199 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 60 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 523 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3568 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 486 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4142 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 1.36 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.97 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.95 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 19.8594 -6.6453 23.5309 REMARK 3 T TENSOR REMARK 3 T11: -0.1807 T22: -0.0185 REMARK 3 T33: -0.1689 T12: 0.0607 REMARK 3 T13: 0.0239 T23: 0.0601 REMARK 3 L TENSOR REMARK 3 L11: 1.9568 L22: 1.5188 REMARK 3 L33: 1.4975 L12: -0.7025 REMARK 3 L13: -0.3677 L23: 0.2019 REMARK 3 S TENSOR REMARK 3 S11: -0.0259 S12: -0.2870 S13: -0.1399 REMARK 3 S21: -0.0462 S22: 0.0234 S23: 0.0123 REMARK 3 S31: -0.0179 S32: 0.2566 S33: 0.0025 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -3.1279 6.7554 21.7377 REMARK 3 T TENSOR REMARK 3 T11: -0.1415 T22: -0.0795 REMARK 3 T33: -0.1839 T12: 0.0710 REMARK 3 T13: 0.0345 T23: 0.0061 REMARK 3 L TENSOR REMARK 3 L11: 3.1168 L22: 0.6508 REMARK 3 L33: 2.1137 L12: 0.1327 REMARK 3 L13: 0.1335 L23: -0.1891 REMARK 3 S TENSOR REMARK 3 S11: -0.0271 S12: -0.1326 S13: 0.0112 REMARK 3 S21: 0.0205 S22: 0.1357 S23: 0.0184 REMARK 3 S31: -0.1846 S32: -0.2127 S33: -0.1087 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6ZOR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-JUL-20. REMARK 100 THE DEPOSITION ID IS D_1292107397. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-AUG-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97627 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.32 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33218 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.970 REMARK 200 RESOLUTION RANGE LOW (A) : 47.080 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.05400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.97 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.99700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 6SUO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, MAGNESIUM CHLORIDE, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 53.28000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 26.25000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 53.28000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 26.25000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2730 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 709 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PHE A 461 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 LEU A 466 REMARK 465 LYS A 467 REMARK 465 SER A 468 REMARK 465 LYS A 529 REMARK 465 SER A 530 REMARK 465 LYS A 531 REMARK 465 ASN A 532 REMARK 465 THR A 553 REMARK 465 SER A 554 REMARK 465 GLY B 303 REMARK 465 SER B 304 REMARK 465 HIS B 305 REMARK 465 ASP B 332 REMARK 465 PRO B 333 REMARK 465 THR B 334 REMARK 465 ARG B 335 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 SER B 464 REMARK 465 THR B 465 REMARK 465 LEU B 466 REMARK 465 LYS B 467 REMARK 465 SER B 468 REMARK 465 LYS B 529 REMARK 465 SER B 530 REMARK 465 LYS B 531 REMARK 465 ASN B 532 REMARK 465 ARG B 548 REMARK 465 LEU B 549 REMARK 465 HIS B 550 REMARK 465 ALA B 551 REMARK 465 PRO B 552 REMARK 465 THR B 553 REMARK 465 SER B 554 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 330 CG CD OE1 OE2 REMARK 470 TYR A 331 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP A 332 CG OD1 OD2 REMARK 470 THR A 334 OG1 CG2 REMARK 470 ARG A 335 CG CD NE CZ NH1 NH2 REMARK 470 PRO A 336 CG CD REMARK 470 PHE A 337 CG CD1 CD2 CE1 CE2 CZ REMARK 470 SER A 338 OG REMARK 470 GLU A 339 CG CD OE1 OE2 REMARK 470 MET A 342 CG SD CE REMARK 470 GLU A 380 OE1 OE2 REMARK 470 GLU A 397 CG CD OE1 OE2 REMARK 470 LYS A 401 NZ REMARK 470 ASP A 411 CG OD1 OD2 REMARK 470 ARG A 412 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 413 CG OD1 ND2 REMARK 470 LYS A 416 CG CD CE NZ REMARK 470 SER A 417 OG REMARK 470 VAL A 418 CG1 CG2 REMARK 470 GLU A 419 CG CD OE1 OE2 REMARK 470 MET A 421 CG SD CE REMARK 470 VAL A 422 CG1 CG2 REMARK 470 GLU A 423 CG CD OE1 OE2 REMARK 470 MET A 437 CG SD CE REMARK 470 VAL A 458 CG1 CG2 REMARK 470 TYR A 459 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 THR A 460 OG1 CG2 REMARK 470 LEU A 469 CG CD1 CD2 REMARK 470 GLU A 470 CG CD OE1 OE2 REMARK 470 GLU A 471 CG CD OE1 OE2 REMARK 470 LYS A 472 CG CD CE NZ REMARK 470 ARG A 477 CD NE CZ NH1 NH2 REMARK 470 LYS A 492 CG CD CE NZ REMARK 470 GLN A 498 CG CD OE1 NE2 REMARK 470 LYS A 520 CE NZ REMARK 470 VAL A 533 CG1 CG2 REMARK 470 VAL A 534 CG1 CG2 REMARK 470 ASP A 538 CG OD1 OD2 REMARK 470 GLU A 542 CG CD OE1 OE2 REMARK 470 ARG A 548 CG CD NE CZ NH1 NH2 REMARK 470 MET B 306 CG SD CE REMARK 470 LEU B 308 CG CD1 CD2 REMARK 470 SER B 309 OG REMARK 470 ASP B 313 CG OD1 OD2 REMARK 470 TYR B 331 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 PHE B 337 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU B 339 CG CD OE1 OE2 REMARK 470 ASP B 351 CG OD1 OD2 REMARK 470 LYS B 362 CD CE NZ REMARK 470 VAL B 368 CG1 CG2 REMARK 470 HIS B 377 CG ND1 CD2 CE1 NE2 REMARK 470 GLU B 397 OE1 OE2 REMARK 470 LYS B 401 CE NZ REMARK 470 LEU B 409 CD1 CD2 REMARK 470 ASN B 413 CG OD1 ND2 REMARK 470 GLN B 414 CG CD OE1 NE2 REMARK 470 LYS B 416 CG CD CE NZ REMARK 470 SER B 417 OG REMARK 470 VAL B 418 CG1 CG2 REMARK 470 GLU B 419 CG CD OE1 OE2 REMARK 470 GLU B 423 CG CD OE1 OE2 REMARK 470 PHE B 425 CG CD1 CD2 CE1 CE2 CZ REMARK 470 MET B 437 CG SD CE REMARK 470 VAL B 458 CG1 CG2 REMARK 470 TYR B 459 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 THR B 460 OG1 CG2 REMARK 470 PHE B 461 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU B 469 CG CD1 CD2 REMARK 470 GLU B 470 CG CD OE1 OE2 REMARK 470 GLU B 471 CG CD OE1 OE2 REMARK 470 ASP B 473 CG OD1 OD2 REMARK 470 LYS B 492 CG CD CE NZ REMARK 470 LYS B 520 CE NZ REMARK 470 SER B 527 OG REMARK 470 MET B 528 SD CE REMARK 470 VAL B 533 CG1 CG2 REMARK 470 VAL B 534 CG1 CG2 REMARK 470 ASP B 538 CG OD1 OD2 REMARK 470 LEU B 539 CG CD1 CD2 REMARK 470 GLU B 542 CG CD OE1 OE2 REMARK 470 HIS B 547 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 336 N - CA - CB ANGL. DEV. = 7.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 408 71.17 -151.71 REMARK 500 VAL B 534 135.79 -39.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 QNH B 601 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue QNH A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue QNH B 601 DBREF 6ZOR A 307 554 UNP P03372 ESR1_HUMAN 307 554 DBREF 6ZOR B 307 554 UNP P03372 ESR1_HUMAN 307 554 SEQADV 6ZOR GLY A 303 UNP P03372 EXPRESSION TAG SEQADV 6ZOR SER A 304 UNP P03372 EXPRESSION TAG SEQADV 6ZOR HIS A 305 UNP P03372 EXPRESSION TAG SEQADV 6ZOR MET A 306 UNP P03372 EXPRESSION TAG SEQADV 6ZOR SER A 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 6ZOR SER A 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 6ZOR SER A 530 UNP P03372 CYS 530 ENGINEERED MUTATION SEQADV 6ZOR SER A 536 UNP P03372 LEU 536 ENGINEERED MUTATION SEQADV 6ZOR GLY B 303 UNP P03372 EXPRESSION TAG SEQADV 6ZOR SER B 304 UNP P03372 EXPRESSION TAG SEQADV 6ZOR HIS B 305 UNP P03372 EXPRESSION TAG SEQADV 6ZOR MET B 306 UNP P03372 EXPRESSION TAG SEQADV 6ZOR SER B 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 6ZOR SER B 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 6ZOR SER B 530 UNP P03372 CYS 530 ENGINEERED MUTATION SEQADV 6ZOR SER B 536 UNP P03372 LEU 536 ENGINEERED MUTATION SEQRES 1 A 252 GLY SER HIS MET ALA LEU SER LEU THR ALA ASP GLN MET SEQRES 2 A 252 VAL SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SEQRES 3 A 252 SER GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER SEQRES 4 A 252 MET MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU SEQRES 5 A 252 VAL HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE SEQRES 6 A 252 VAL ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU SEQRES 7 A 252 SER ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP SEQRES 8 A 252 ARG SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO SEQRES 9 A 252 ASN LEU LEU LEU ASP ARG ASN GLN GLY LYS SER VAL GLU SEQRES 10 A 252 GLY MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SEQRES 11 A 252 SER ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE SEQRES 12 A 252 VAL CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL SEQRES 13 A 252 TYR THR PHE LEU SER SER THR LEU LYS SER LEU GLU GLU SEQRES 14 A 252 LYS ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP SEQRES 15 A 252 THR LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU SEQRES 16 A 252 GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE SEQRES 17 A 252 LEU SER HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU SEQRES 18 A 252 HIS LEU TYR SER MET LYS SER LYS ASN VAL VAL PRO SER SEQRES 19 A 252 TYR ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG LEU SEQRES 20 A 252 HIS ALA PRO THR SER SEQRES 1 B 252 GLY SER HIS MET ALA LEU SER LEU THR ALA ASP GLN MET SEQRES 2 B 252 VAL SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SEQRES 3 B 252 SER GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER SEQRES 4 B 252 MET MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU SEQRES 5 B 252 VAL HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE SEQRES 6 B 252 VAL ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU SEQRES 7 B 252 SER ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP SEQRES 8 B 252 ARG SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO SEQRES 9 B 252 ASN LEU LEU LEU ASP ARG ASN GLN GLY LYS SER VAL GLU SEQRES 10 B 252 GLY MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SEQRES 11 B 252 SER ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE SEQRES 12 B 252 VAL CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL SEQRES 13 B 252 TYR THR PHE LEU SER SER THR LEU LYS SER LEU GLU GLU SEQRES 14 B 252 LYS ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP SEQRES 15 B 252 THR LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU SEQRES 16 B 252 GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE SEQRES 17 B 252 LEU SER HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU SEQRES 18 B 252 HIS LEU TYR SER MET LYS SER LYS ASN VAL VAL PRO SER SEQRES 19 B 252 TYR ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG LEU SEQRES 20 B 252 HIS ALA PRO THR SER HET QNH A 601 33 HET QNH B 601 31 HETNAM QNH 6-[(6~{S},8~{R})-8-METHYL-7-[2,2,2-TRIS(FLUORANYL) HETNAM 2 QNH ETHYL]-3,6,8,9-TETRAHYDROPYRAZOLO[4,3-F]ISOQUINOLIN-6- HETNAM 3 QNH YL]-~{N}-(1-PROPYLAZETIDIN-3-YL)PYRIDIN-3-AMINE FORMUL 3 QNH 2(C24 H29 F3 N6) FORMUL 5 HOH *28(H2 O) HELIX 1 AA1 MET A 306 LEU A 310 5 5 HELIX 2 AA2 THR A 311 GLU A 323 1 13 HELIX 3 AA3 PRO A 336 ALA A 340 5 5 HELIX 4 AA4 SER A 341 ARG A 363 1 23 HELIX 5 AA5 GLY A 366 LEU A 370 5 5 HELIX 6 AA6 THR A 371 MET A 396 1 26 HELIX 7 AA7 ARG A 412 LYS A 416 1 5 HELIX 8 AA8 GLY A 420 MET A 438 1 19 HELIX 9 AA9 GLN A 441 SER A 456 1 16 HELIX 10 AB1 GLU A 470 ALA A 493 1 24 HELIX 11 AB2 THR A 496 MET A 528 1 33 HELIX 12 AB3 SER A 536 HIS A 547 1 12 HELIX 13 AB4 ARG A 548 HIS A 550 5 3 HELIX 14 AB5 MET B 306 LEU B 310 5 5 HELIX 15 AB6 THR B 311 ALA B 322 1 12 HELIX 16 AB7 SER B 338 ARG B 363 1 26 HELIX 17 AB8 THR B 371 SER B 395 1 25 HELIX 18 AB9 ARG B 412 LYS B 416 1 5 HELIX 19 AC1 GLY B 420 MET B 438 1 19 HELIX 20 AC2 GLN B 441 SER B 456 1 16 HELIX 21 AC3 GLY B 457 PHE B 461 5 5 HELIX 22 AC4 GLU B 470 ALA B 493 1 24 HELIX 23 AC5 THR B 496 TYR B 526 1 31 HELIX 24 AC6 SER B 536 HIS B 547 1 12 SHEET 1 AA1 2 LYS A 401 ALA A 405 0 SHEET 2 AA1 2 LEU A 408 ASP A 411 -1 O LEU A 410 N LEU A 402 SHEET 1 AA2 2 LYS B 401 ALA B 405 0 SHEET 2 AA2 2 LEU B 408 ASP B 411 -1 O LEU B 410 N LEU B 402 SITE 1 AC1 14 LEU A 346 THR A 347 ASP A 351 GLU A 353 SITE 2 AC1 14 LEU A 384 LEU A 387 MET A 388 ARG A 394 SITE 3 AC1 14 PHE A 404 GLY A 521 LEU A 525 VAL A 533 SITE 4 AC1 14 LEU A 539 HOH A 702 SITE 1 AC2 14 LEU B 346 THR B 347 ALA B 350 GLU B 353 SITE 2 AC2 14 LEU B 387 MET B 388 LEU B 391 ARG B 394 SITE 3 AC2 14 PHE B 404 GLY B 521 LEU B 525 VAL B 533 SITE 4 AC2 14 PRO B 535 HOH B 707 CRYST1 106.560 52.500 86.010 90.00 93.06 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009384 0.000000 0.000502 0.00000 SCALE2 0.000000 0.019048 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011643 0.00000